NCT01671020 - Clinical Trials for Single Oral Dose of 60mg Fimasartan and Single IV Infusion of 30mg Fimasartan to Evaluate the Absolute Bioavailability of Kanarb® Tablet (Fimasartan) in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Healthy

Interventions

DRUG

Fimasartan

Period 1 fisrt administration of fimasartan 60mg Period 2 second administration of fimasartan 30mg

DRUG

Fimasartan

Period 1 first administration of fimasartan 30mg Period 2 second administration of fimasartan 60mg

Trial Locations (1)

Inje University Busan Paik Hospital, Busan